Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
oral contraceptive
vaginal gel |
| gptkbp:activeIngredient |
citric acid
lactic acid potassium bitartrate |
| gptkbp:applicationTiming |
immediately before or up to 1 hour before intercourse
|
| gptkbp:approvalYear |
2020
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:contraindication |
recurrent urinary tract infections
known hypersensitivity to ingredients |
| gptkbp:form |
non-hormonal
pre-filled applicator |
| https://www.w3.org/2000/01/rdf-schema#label |
Phexxi
|
| gptkbp:indication |
prevention of pregnancy
|
| gptkbp:manufacturer |
gptkb:Evofem_Biosciences
|
| gptkbp:marketedIn |
gptkb:United_States
|
| gptkbp:mechanismOfAction |
maintains vaginal pH to reduce sperm motility
|
| gptkbp:pregnancyCategory |
not for use during pregnancy
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
vaginal
|
| gptkbp:sideEffect |
urinary tract infection
bacterial vaginosis vulvovaginal burning sensation vulvovaginal itching vulvovaginal pain |
| gptkbp:bfsParent |
gptkb:Evofem_Biosciences
|
| gptkbp:bfsLayer |
7
|